Opko Health, Inc.
OPK
$1.29
-$0.015-1.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -18.34% | 5.76% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -18.34% | 5.76% | |||
| Cost of Revenue | 6.78% | -20.26% | |||
| Gross Profit | -78.28% | 377.45% | |||
| SG&A Expenses | -11.85% | -31.74% | |||
| Depreciation & Amortization | -2.37% | -0.44% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.16% | -22.83% | |||
| Operating Income | -102.69% | 69.11% | |||
| Income Before Tax | -309.83% | -27.77% | |||
| Income Tax Expenses | -127.55% | -10.97% | |||
| Earnings from Continuing Operations | -582.02% | -43.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -582.02% | -43.64% | |||
| EBIT | -102.69% | 69.11% | |||
| EBITDA | -380.01% | 89.05% | |||
| EPS Basic | -586.47% | -42.18% | |||
| Normalized Basic EPS | -150.00% | 224.37% | |||
| EPS Diluted | -672.16% | -44.65% | |||
| Normalized Diluted EPS | -170.33% | 227.11% | |||
| Average Basic Shares Outstanding | -0.77% | -2.57% | |||
| Average Diluted Shares Outstanding | -29.44% | -4.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||